Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells

被引:7
|
作者
Page, G [1 ]
Chalon, S
Emond, P
Maloteaux, JM
Hermans, E
机构
[1] Catholic Univ Louvain, Lab Pharmacol expt, FARL, B-1200 Brussels, Belgium
[2] Fac Med & Pharm, UPRESEA 1223, GEMCI, F-86005 Poitiers, France
[3] INSERM, Lab Biophys Med & Pharmaceut, F-38200 Tours, France
关键词
neuronal dopamine transporter; DA uptake; PE2I; GBR; 12935; COS cells; selective inhibitor;
D O I
10.1016/S0197-0186(01)00086-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of (E)-N-(3-iodoprop-2-enyl)-2beta-Carbomethoxy-3beta-(4'-methylphenyl) nortropane (PE2I) with the rat neuronal dopamine transporter (DAT) was studied in transfected COS cells by measuring its ability to inhibit DA uptake and by measuring its affinity in radioligand binding experiments. Saturable [H-3]DA uptake was measured in COS cells transiently transfected with the cDNA sequence encoding the rat DAT. Pharmacological characterisation of this uptake revealed functional properties with a V-max,a value of 45.05 +/- 2.62 pmol/mg protein per min and a K-m value of 2.86 +/- 0.28 muM. The specific [H-3]DA uptake was fully inhibited by 1 muM PE2I. Concentration response curves revealed the high potency of PE2I in inhibiting DA uptake (pEC(50) value of 8.70 +/- 0.33), 25 times higher than that observed for the reference DAT inhibitor, GBR 12935. On crude homogenates from transfected COS cells, PE2I displaced the specific binding of [3 H]GBR 12935 with a PKi value of 7.73 +/- 0.13. Accordingly, [I-125]PE2I was found to specifically recognise a single binding site population which is almost completely displaced by GBR 12935 and nomifensine. Saturation experiments revealed the high affinity of [I-125]PE2I (K-D value of 3.8 +/- 0.63 nM) that correlates with the high potency of PEN in inhibiting the [H-3]DA uptake. This contrasts with the results obtained with GBR 12935 for which a discrepancy was found between its high affinity in binding assays (KD value of 0.43 +/- 0.04 nM) and its rather low potency in functional assays (pEC50 value of 7.30 +/- 0.05). A relatively high level of [H-3]GBR 12935 binding was detected in non transfected COS cells. Such nomifensine resistant binding is attributed to the interaction of GBR 12935 with cytochrome P-450 as it was displaced by cis-(Z)-flupentixol (an inhibitor of cytochrome P-450). Such interaction was not observed using PE2I. Taken together, these data demonstrate that PE2I was a highly potent inhibitor of cloned DAT compared with GBR 12935 and provided a useful tool for further investigations in cells transfected with cDNA encoding the DAT. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:105 / 113
页数:9
相关论文
共 46 条
  • [31] Potential of [18F]β-CFT-FE (2β-carbomethoxy-3β-(4-fluorophenyl)-8-(2-[18F]fluoroethyl)nortropane) as a dopamine transporter ligand:: A PET study in the conscious monkey brain
    Harada, N
    Ohba, H
    Fukumoto, D
    Kakiuchi, T
    Tsukada, H
    SYNAPSE, 2004, 54 (01) : 37 - 45
  • [32] Shape analysis of 123I-N-ω-fluoropropyl-2-β-carbomethoxy-3β-(4-iodophenyl) nortropane single-photon emission computed tomography images in the assessment of patients with parkinsonian syndromes
    Staff, Roger T.
    Ahearn, Trevor S.
    Wilson, Kevin
    Counsell, Carl E.
    Taylor, Kate
    Caslake, Robert
    Davidson, Joyce E.
    Gemmell, Howard G.
    Murray, Alison D.
    NUCLEAR MEDICINE COMMUNICATIONS, 2009, 30 (03) : 194 - 201
  • [33] Simplified synthesis of N-(3-[18F]fluoropropyl)-2β-carbomethoxy-3β-(4-fluorophenyl)nortropane ([18F]β-CFT-FP) using [18F]fluoropropyl tosylate as the labelling reagent
    Koivula, T
    Perhola, O
    Kämäräinen, EL
    Lipponen, T
    Vepsäläinen, J
    Solin, O
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 (06): : 463 - 471
  • [34] 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease
    Koros, Christos
    Simitsi, Athina
    Prentakis, Andreas
    Beratis, Ion
    Papadimitriou, Dimitra
    Kontaxopoulou, Dionysia
    Fragkiadaki, Stella
    Papagiannakis, Nikolaos
    Seibyl, John
    Marek, Kenneth
    Papageorgiou, Sokratis G.
    Trapali, Xenia Geronicola
    Stamelou, Maria
    Stefanis, Leonidas
    MOVEMENT DISORDERS, 2018, 33 (11) : 1734 - 1739
  • [35] Seasonal variation of availability of serotonin transporter binding sites in healthy female subjects as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography
    Neumeister, A
    Pirker, W
    Willeit, M
    Praschak-Rieder, N
    Asenbaum, S
    Brücke, T
    Kasper, S
    BIOLOGICAL PSYCHIATRY, 2000, 47 (02) : 158 - 160
  • [36] Detection of reduced dopamine transporter availability by 123I-N-omega-fluoropropyl-2-beta-carbomethoxy-3-beta (4-iodophenyl) nortropane single-photon emission computed tomography in a patient of frontotemporal dementia with motor neuron disease
    Kobayashi, Ryota
    Hayashi, Hiroshi
    Kawakatsu, Shinobu
    Nagasawa, Hiroki
    Koyama, Shingo
    Ishizawa, Kenichi
    Otani, Koichi
    PSYCHOGERIATRICS, 2020, 20 (05) : 799 - 801
  • [37] 123I-2-carbomethoxy-3-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and 123I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study
    Tiraboschi, Pietro
    Corso, Angelo
    Guerra, Ugo Paolo
    Nobili, Flavio
    Piccardo, Arnoldo
    Calcagni, Maria Lucia
    Volterrani, Duccio
    Cecchin, Diego
    Tettamanti, Mauro
    Antelmi, Luigi
    Vidale, Simone
    Sacco, Leonardo
    Merello, Maria
    Stefanini, Stefano
    Micheli, Anna
    Vai, Paola
    Capitanio, Selene
    Gabanelli, Sara Vincenzina
    Riva, Riccardo
    Pinto, Patrizia
    Biffi, Ave Maria
    Muscio, Cristina
    ANNALS OF NEUROLOGY, 2016, 80 (03) : 368 - 378
  • [38] Performance of compressed sensing-based iterative reconstruction for single-photon emission computed tomography from undersampled projection data: a simulation study in 123I-N-ω-fluoropropyI-2β-carbomethoxy-3β-(4-iodophenyl)nortropane imaging
    Matsutomo, Norikazu
    Fukaya, Kaoru
    Hashimoto, Takeyuki
    Yamamoto, Tomoaki
    Sato, Eisuke
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (02) : 106 - 114
  • [39] ANTIPEPTIDE ANTIBODIES LOCALIZE N-(4-AZIDO-3-[I-125] IODOPHENETHYL)SPIPERONE BINDING TO THE CARBOXYL-TERMINAL PORTION OF THE D2 DOPAMINE RECEPTOR
    DAVID, C
    FUCHS, S
    MOLECULAR PHARMACOLOGY, 1991, 40 (05) : 712 - 716
  • [40] Binding domains for blockers and substrates on the cloned human dopamine transporter studied by protection against N-ethylmaleimide-induced reduction of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)[H-3]tropane ([H-3]WIN 35,428) binding
    Reith, MEA
    Xu, C
    Coffey, LL
    BIOCHEMICAL PHARMACOLOGY, 1996, 52 (09) : 1435 - 1446